Prostate cancer: Blood test could help target treatment 

Medical History Reveals Multiple Sclerosis Begins to Impact Patients Sooner
May 12, 2017
Pembrolizumab Combination Granted Accelerated Approval for Non-Small Cell Lung Cancer 
May 15, 2017
Show all

Prostate cancer: Blood test could help target treatment 

A blood test could provided more targeted treatment for prostate cancer.

A blood test has been developed that could help target treatment for men with advanced prostate cancer.

Cancer researchers in Europe analysed blood from 265 men with the disease.

They found those with multiple copies of a particular gene did not respond to abiraterone and enzalutamide – drugs commonly used to treat advanced cases.

More trials are needed but the team hope the test could prevent thousands of men undergoing unnecessary treatment and allow more personalised care.

The drugs abiraterone and enzalutamide are given to men whose cancer is no longer responding to traditional hormone therapy and has started to spread.

Read full article: Prostate cancer: Blood test could help target treatment – BBC News

Read Full Article: Prostate cancer: Blood test could help target treatment – BBC News

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.